Jill Madden, Ph.D. is a postdoctoral fellow in the lab of Dr. Jeremy Chien at the University of Kansas Medical Center, Department of Cancer Biology. Dr. Madden earned her Bachelor of Science degree in Genetics at Iowa State University where she continued her education to earn a Ph.D. in Genetics with a minor in Toxicology. Under the mentorship of Dr. Aileen Keating, her Ph.D. dissertation focused on determining the mechanism of ovarian follicle death induced by the chemotherapy drug cyclophosphamide, specifically evaluating the role of xenobiotic metabolism and autophagy. Currently, Dr. Madden is investigating the therapeutic potential of targeting the TP53-FoxM1 axis in ovarian cancer and the molecular mechanisms by which FoxM1 inhibitors enhance sensitivity to carboplatin in ovarian cancer. Dr. Madden was also a recipient of the 2015 University of Kansas BIRCWH (Building Interdisciplinary Research Careers in Women’s Health) K12 Postdoctoral Fellowship Award.